Stockscreener 앱 받기
41.71
1.98%
0.81
시간 외 거래:
41.71
Palvella Therapeutics Inc 주식(PVLA)의 최신 뉴스
Detecting price anomalies in Palvella Therapeutics Inc. with AIFree Daily Chart Pattern Stock Forecast - Newser
What indicators show strength in Palvella Therapeutics Inc.AI Powered Stock Market Trend Forecast - Newser
Is Palvella Therapeutics Inc. stock entering bullish territoryBuy Point Strategy with Profit Protection - Newser
What institutional flow reveals about Palvella Therapeutics Inc.Weekly Growth Portfolio Performance Summary - Newser
Palvella Therapeutics to Report Q2 Financials and Corporate Update on August 14 - MSN
Will Palvella Therapeutics Inc. price bounce be sustainableInvestment Life Cycle Planning Summary - Newser
Palvella Therapeutics CEO to Speak at Canaccord Genuity Growth Conference - MSN
Is Palvella Therapeutics Inc. forming a reversal patternFree Reliable Investment Entry Point Signals - Newser
How Palvella Therapeutics Inc. stock performs during market volatilityAsset Allocation Summary With Future Outlook - Newser
Will Palvella Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsBreakout Monitoring with Momentum Analysis - Newser
Palvella Therapeutics Inc. stock trend forecastSwing Gain Strategy with Entry Forecast - Newser
How hedge fund analytics apply to Palvella Therapeutics Inc. stockDaily Equity Signal Strength Summary Report - Newser
Key External Factors That Drive Palvella Therapeutics Inc. Stock Price MovementsFree Daily Chart Pattern Stock Forecast - Newser
Will Palvella Therapeutics Inc. stock recover after recent dropShort-Term Upside Breakout Forecast System - Newser
Risk vs reward if holding onto Palvella Therapeutics Inc.Support and Resistance Zone Summary Chart - Newser
Does Palvella Therapeutics Inc. fit your quant trading modelStock Market Trend and Pattern Analysis - Newser
Exit strategy if you’re trapped in Palvella Therapeutics Inc.Free Step-by-Step Stock Investment Guide - Newser
Real time scanner hits for Palvella Therapeutics Inc. explainedProfitable Trading Blueprint with Entry Zones - Newser
Palvella Therapeutics Inc. stock volume spike explainedShort Term Profit Strategy with Entry Cues - Newser
Palvella Therapeutics Q2 2025 Earnings Call Scheduled for August 14 | PVLA Stock News - Stock Titan
Analysts Set Expectations for PVLA Q2 Earnings - Defense World
How to read the order book for Palvella Therapeutics Inc.AI Trade Signal Forecast with Chart Logic - Newser
What makes Palvella Therapeutics Inc. stock price move sharplyHigh Yield Signals with Entry Timing - Newser
This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Palvella Therapeutics (NASDAQ:PVLA) Rating Increased to Strong-Buy at Lifesci Capital - Defense World
Palvella Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
Raymond James Initiates Palvella Therapeutics(PVLA.US) With Buy Rating, Announces Target Price $54 - 富途牛牛
Raymond James initiates Palvella Therapeutics stock with Outperform rating By Investing.com - Investing.com Canada
Lifesci Capital Initiates Coverage on Palvella Therapeutics (NASDAQ:PVLA) - Defense World
Lifesci Capital Upgrades Palvella Therapeutics (NASDAQ:PVLA) to “Strong-Buy” - Defense World
Palvella Therapeutics CEO to Share Rare Disease Pipeline Updates at Major Growth Conference - Stock Titan
Palvella Therapeutics (NASDAQ:PVLA) Coverage Initiated by Analysts at Lifesci Capital - Defense World
Palvella Therapeutics (NASDAQ:PVLA) Stock Rating Upgraded by Lifesci Capital - Defense World
Palvella Therapeutics Inc. Shows Risk Reward Favoring UpsideEntry Plan for Oversold Reversal Stocks Released - metal.it
Analysts Initiate Coverage on Akero Therapeutics, AeroVironment, Wave Life Sciences, Palvella Therapeutics, and WeRide Inc. - AInvest
This AeroVironment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
1.02%
3.70%
자본화:
|
볼륨(24시간):